DOCSLIB.ORG

Translation Initiation Factor Eif4f Modifies the Dexamethasone Response in Multiple Myeloma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Translation Initiation Factor Eif4f Modifies the Dexamethasone Response in Multiple Myeloma Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma Francis Roberta, William Romanb, Alexandre Bramoulléc, Christof Fellmannd, Anne Roulstonc, Chaim Shustikb, John A. Porco, Jr.e, Gordon C. Shorea,c, Michael Sebagb,1, and Jerry Pelletiera,c,f,1 Departments of aBiochemistry, bMedicine and Hematology, and fOncology, and cThe Rosalind and Morris Goodman Cancer Research Center, McGill University, Montreal, QC, Canada H3G 1Y6; dMirimus, Inc., Cold Spring Harbor, NY 11724; and eCenter for Chemical Methodology and Library Development, Boston University, Boston, MA 02215 Edited* by David E. Housman, Massachusetts Institute of Technology, Cambridge, MA, and approved August 5, 2014 (received for review February 24, 2014) Enhanced protein synthesis capacity is associated with increased PI3K/mTOR and MAPK pathways intimately impinge on the tumor cell survival, proliferation, and resistance to chemother- translation pathway, linking this energetically demanding process apy. Cancers like multiple myeloma (MM), which display elevated to intra- and extracellular proliferation and survival cues (4). As activity in key translation regulatory nodes, such as the PI3K/ well, overexpression of MYC, a master regulator of ribosome mammalian target of rapamycin and MYC-eukaryotic initiation biogenesis and translation, is frequently observed in MM (5–7) factor (eIF) 4E pathways, are predicted to be particularly sensitive and is associated with a poor prognosis (7, 8). Deregulated to therapeutic strategies that target this process. To identify novel translational control is therefore a central feature of MM, with vulnerabilities in MM, we undertook a focused RNAi screen in perturbations occurring at the level of core components and which components of the translation apparatus were targeted. regulatory pathways. Our screen was designed to identify synthetic lethal relationships One of the best-studied MYC effectors and a downstream between translation factors or regulators and dexamethasone target of the PI3K/mTOR pathway implicated in translational (DEX), a corticosteroid used as frontline therapy in this disease. We control is eIF4F (4, 5, 9). eIF4F is a heterotrimeric complex find that suppression of all three subunits of the eIF4F cap-binding consisting of: (i) eIF4E, a cap-binding protein; (ii) eIF4A, an complex synergizes with DEX in MM to induce cell death. Using RNA helicase implicated in remodeling mRNA structure; and a suite of small molecules that target various activities of eIF4F, we (iii) eIF4G, a large scaffolding protein. The association of eIF4E observed that cell survival and DEX resistance are attenuated with the eIF4F complex is regulated by mTOR, with mTOR upon eIF4F inhibition in MM cell lines and primary human samples. activation leading to stimulation of eIF4F formation. Elevated Levels of MYC and myeloid cell leukemia 1, two known eIF4F- PI3K/mTOR signaling flux or increased MYC levels exert pro- responsive transcripts and key survival factors in MM, were found activating effects on cap-dependent translation, and con- reduced upon eIF4F inhibition, and their independent suppres- sequently on cellular proliferation and survival (10). sion also synergized with DEX. Inhibition of eIF4F in MM exerts The PI3K/mTOR axis is being probed as a therapeutic target pleotropic effects unraveling a unique therapeutic opportunity. in MM (11). MM cells are sensitive to mTOR inhibition by rapa- mycin-related molecules (12), but the presence of an mTOR- silvestrol | hippuristanol | eIF4A | RNAi screening S6K-insulin receptor substrate-1 negative-feedback loop, which reactivates PI3K and AKT upon mTOR inhibition, diminishes ultiple myeloma (MM) is a bone marrow-derived malig- the efficacy of rapalogs (13). Second-generation mTOR complex Mnancy of plasma cells that typically produce a monoclonal (mTORC) kinase inhibitors (KIs) (e.g., OSI-027) and dual-spec- immunoglobulin (Ig). It is the second most frequent hema- ificity PI3K/mTOR KIs [e.g., (NVP)-BEZ235] avoid PI3K/AKT tological neoplasm in adults, with ∼20,000 newly diagnosed GENETICS cases annually in the United States. Corticosteroids [predni- Significance sone and dexamethasone (DEX)] are common to all treat- ment regimens, usually in combination with an alkylating Multiple myeloma (MM) is a cancer that develops in the bone agent (e.g., melphalan) or more recently introduced agents, marrow and remains incurable to this day. It is a cancer type such as proteasome inhibitors (bortezomib and carfilzomib) that shows hallmarks of deregulated protein synthesis control. and immunomodulatory agents (thalidomide, lenalidomide, and To uncover new vulnerabilities in this disease, we performed pomalidomide). Despite the single-agent activity of these novel a focused RNAi screen to identify components of the trans- treatment options, enhanced clinical activity is observed when lation apparatus that, when depleted, would sensitize tumor they are used in combination with DEX. cells to dexamethasone (DEX), a component of frontline ther- The MM genomic landscape includes recurrent DNA trans- apy in this cancer. We found that suppression of eukaryotic locations involving mostly the IgH locus, chromosomal gains and initiation factor 4F, a heterotrimeric complex required for cap- losses, and a significant number of mutations in genes involved in dependent translation initiation, is a modifier of the DEX re- translation and its regulation (1). In nearly 50% of patients an- sponse in MM. Our efforts uncover a previously unidentified alyzed, mutations were documented in the following: DIS3, vulnerability in MM that should be explored clinically. a component of the exosome and predicted to increase mRNA content; FAM46C, a gene product functionally related to a reg- Author contributions: F.R., A.R., C.S., G.C.S., M.S., and J.P. designed research; F.R., W.R., ulator of protein synthesis; XBP1, an unfolded response protein and M.S. performed research; A.B., C.F., and J.A.P. contributed new reagents/analytic tools; F.R., W.R., A.B., C.F., A.R., C.S., J.A.P., G.C.S., M.S., and J.P. analyzed data; and F.R. linked to translational control; LRRK2, a eukaryotic initiation and J.P. wrote the paper. factor (eIF) 4E binding protein kinase; and, less frequently, Conflict of interest statement: C.F. is a founder and employee of Mirimus, Inc., a company eIF3B, rpL10, and rpS6KA1 (1). In addition, several signaling that has licensed shRNA technology based on the mir30 system used in this report. pathways are aberrantly activated in MM. These signaling *This Direct Submission article had a prearranged editor. pathways include the PI3K/mammalian target of rapamycin 1To whom correspondence may be addressed. Email: [email protected] or jerry. (mTOR), NF-κB, Ras, Raf, MAPK, and Janus kinase pathways, [email protected]. all of which promote proliferation, evasion of apoptosis, and This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. resistance to therapy (2, 3). Among these signaling pathways, the 1073/pnas.1402650111/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1402650111 PNAS | September 16, 2014 | vol. 111 | no. 37 | 13421–13426 Downloaded by guest on September 24, 2021 activation via the aforementioned feedback loop and show higher Because DEX is used as frontline therapy in this disease, we activity against MM cells than rapalogs (11, 14–16). Rapalogs and designed the screen to identify potential modifiers of the DEX PI3K/mTOR inhibitors have also been shown to enhance the response (Fig. 1A). Among five human MM cell lines tested for cytotoxic effects of DEX (14, 17, 18), which is an effect that can their ability to be infected by our modified pGmP lentivirus, JJN- also be obtained by sequestering eIF4E from the eIF4F complex 3, and KMS-11 were the most efficiently and reproducibly by overexpressing an inhibitory binding partner (18). Herein, we infected, with rates attaining 50–60% following one round of describe the results of a focused RNAi-based screen aimed at infection (Fig. S1A). Whereas KMS-11 cells were sensitive to identifying druggable targets among components of the trans- DEX (IC50 = 50 nM), JJN-3 cells were quite resistant to con- lation apparatus to identify DEX synthetic lethal partners in centrations as high as 3 μM(Fig. S1B), as previously reported MM. Our results define eIF4F as a target for the treatment of (19). Upon exposure to DEX, JJN-3 cells activated expression MM, identify a small-molecule inhibitor with low nanomolar of the DEX-responsive glucocorticoid-induced leucine zipper potency against human MM cells, and demonstrate that in- (GILZ) (20), indicating that DEX resistance in JJN-3 cells is hibition of translation is synthetic lethal with DEX when applied not due to defective glucocorticoid receptor (GR) signaling to MM tumor cells. (Fig. S1C). GILZ induction is mediated by DEX in our setting because it is blocked by the antagonist RU-486 (Fig. S1C). Results These results establish JJN-3 cells as a DEX-resistant cell line RNAi-Based Synthetic Lethal Screen Identifies Modifiers of DEX with a functional GR/GILZ signaling axis. Sensitivity in MM. Given the profound deregulation at the level We generated a custom, sequence-verified and arrayed, miR30- of translation that has been documented in MM (Introduction), we based shRNA library targeting amino acyl-tRNA synthetases, large chose to perform an RNAi-based screen targeting this pathway and small ribosomal proteins, initiation factors, elongation fac- to identify
Load more

Recommended publications
  • From Thermus Thermophilus HB8
    Crystal Structure of Elongation Factor P from Thermus thermophilus HB8 Genetic information encoded in messenger RNA molecules. Several proteins were found to possess is translated into protein by the ribosome, which is a domain(s) similar to a portion of tRNA, by which they large ribonucleoprotein complex. It has been clarified interact with the ribosome. The C-terminal domain of that diverse proteins called translation factors and elongation factor G (EF-G) has a shape similar to that RNAs are involved in genetic translation. Translation of the anticodon-stem loop in the elongation factor Tu elongation factor P (EF-P) is one of the translation (EF-Tu)• tRNA• GDPNP ternary complex. Release factors and stimulates the first peptidyl transferase factor 2 (RF2) and ribosome recycling factor (RRF) activity of the ribosome [1]. EF-P is conserved in were also found to possess a protruding domain, by bacteria, and is essential for their viability. Eukarya which they are believed to bind to the ribosome A site and Archaea have an EF-P homologue, eukaryotic [3]. In contrast with these factors, the entire structure initiation factor 5A (eIF-5A). of the EF-P mimics the overall shape of the tRNA We succeeded in the determination of the crystal molecule (Fig. 2). In addition, it is notable that EF-P is structure of EF-P from Thermus thermophilus HB8 at an acidic protein and most of its surface is negatively 1.65 Å resolution, using beamline BL45PX [2]. The charged. The overall tRNA-like shape of the EF-P crystallographic asymmetric unit contains two nearly molecule and the charge distribution seem to be identical EF-P monomers (Fig.
    [Show full text]
  • Ribosomal Initiation Complex-Driven Changes in the Stability and Dynamics of Initiation Factor 2 Regulate the Fidelity of Translation Initiation
    Article Ribosomal Initiation Complex-Driven Changes in the Stability and Dynamics of Initiation Factor 2 Regulate the Fidelity of Translation Initiation Jiangning Wang, Kelvin Caban and Ruben L. Gonzalez Jr. Department of Chemistry, Columbia University, 3000 Broadway, MC3126, New York, NY 10027, USA Correspondence to Ruben L. Gonzalez: [email protected] http://dx.doi.org/10.1016/j.jmb.2014.12.025 Edited by S. A. Woodson Abstract Joining of the large, 50S, ribosomal subunit to the small, 30S, ribosomal subunit initiation complex (IC) during bacterial translation initiation is catalyzed by the initiation factor (IF) IF2. Because the rate of subunit joining is coupled to the IF, transfer RNA (tRNA), and mRNA codon compositions of the 30S IC, the subunit joining reaction functions as a kinetic checkpoint that regulates the fidelity of translation initiation. Recent structural studies suggest that the conformational dynamics of the IF2·tRNA sub-complex forming on the intersubunit surface of the 30S IC may play a significant role in the mechanisms that couple the rate of subunit joining to the IF, tRNA, and codon compositions of the 30S IC. To test this hypothesis, we have developed a single-molecule fluorescence resonance energy transfer signal between IF2 and tRNA that has enabled us to monitor the conformational dynamics of the IF2·tRNA sub-complex across a series of 30S ICs. Our results demonstrate that 30S ICs undergoing rapid subunit joining display a high affinity for IF2 and an IF2·tRNA sub-complex that primarily samples a single conformation. In contrast, 30S ICs that undergo slower subunit joining exhibit a decreased affinity for IF2 and/or a change in the conformational dynamics of the IF2·tRNA sub-complex.
    [Show full text]
  • Initiation Factor Eif5b Catalyzes Second GTP-Dependent Step in Eukaryotic Translation Initiation
    Initiation factor eIF5B catalyzes second GTP-dependent step in eukaryotic translation initiation Joon H. Lee*†, Tatyana V. Pestova†‡§, Byung-Sik Shin*, Chune Cao*, Sang K. Choi*, and Thomas E. Dever*¶ *Laboratory of Gene Regulation and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-2716; ‡Department of Microbiology and Immunology, State University of New York Health Science Center, Brooklyn, NY 11203; and §A. N. Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia Edited by Harry F. Noller, University of California, Santa Cruz, CA, and approved October 31, 2002 (received for review September 19, 2002) Initiation factors IF2 in bacteria and eIF2 in eukaryotes are GTPases In addition, when nonhydrolyzable GDPNP was substituted Met that bind Met-tRNAi to the small ribosomal subunit. eIF5B, the for GTP, eIF5B catalyzed subunit joining; however, the factor eukaryotic ortholog of IF2, is a GTPase that promotes ribosomal was unable to dissociate from the 80S ribosome after subunit subunit joining. Here we show that eIF5B GTPase activity is re- joining (7). quired for protein synthesis. Mutation of the conserved Asp-759 in To dissect the function of the eIF5B G domain and test the human eIF5B GTP-binding domain to Asn converts eIF5B to an model that two GTP molecules are required in translation XTPase and introduces an XTP requirement for subunit joining and initiation, we mutated conserved residues in the eIF5B G translation initiation. Thus, in contrast to bacteria where the single domain and tested the function of the mutant proteins in GTPase IF2 is sufficient to catalyze translation initiation, eukaryotic translation initiation.
    [Show full text]
  • Download Product Insert (PDF)
    PRODUCT INFORMATION eIF4E (human recombinant) Item No. 15137 Overview and Properties Synonyms: eIF-4F 25 kDa subunit, Eukaryotic Translation Initiation Factor 4E, mRNA Cap-binding Protein Source: Recombinant protein expressed in E. coli Amino Acids: 2-217 (full length) Uniprot No.: P06730 Molecular Weight: 25.2 kDa Storage: -80°C (as supplied) Stability: ≥1 year Purity: batch specific (≥55% estimated by SDS-PAGE) Supplied in: 20 mM HEPES, pH 7.5, containing 100 mM potassium chloride, 2 mM DTT, and 10% glycerol Protein Concentration: batch specific mg/ml Image 1 2 3 4 250 kDa · · · · · · · 150 kDa · · · · · · · 100 kDa · · · · · · · 75 kDa · · · · · · · 50 kDa · · · · · · · 37 kDa · · · · · · · 25 kDa · · · · · · · 20 kDa · · · · · · · 15 kDa · · · · · · · Lane 1: MW Markers Lane 2: eIF4E (human recombinant) (4 µg) Lane 3: eIF4E (human recombinant) (2 µg) Lane 4: eIF4E (human recombinant) (1 µg) Representaõve gel image shown; actual purity may vary between each batch. WARNING CAYMAN CHEMICAL THIS PRODUCT IS FOR RESEARCH ONLY - NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE. 1180 EAST ELLSWORTH RD SAFETY DATA ANN ARBOR, MI 48108 · USA This material should be considered hazardous until further information becomes available. Do not ingest, inhale, get in eyes, on skin, or on clothing. Wash thoroughly after handling. Before use, the user must review the complete Safety Data Sheet, which has been sent via email to your institution. PHONE: [800] 364-9897 WARRANTY AND LIMITATION OF REMEDY [734] 971-3335 Buyer agrees to purchase the material subject to Cayman’s Terms and Conditions. Complete Terms and Conditions including Warranty and Limitation of Liability information can be found on our website.
    [Show full text]
  • Translation Initiation Factor Modifications and the Regulation of Protein Synthesis in Apoptotic Cells
    Cell Death and Differentiation (2000) 7, 603 ± 615 ã 2000 Macmillan Publishers Ltd All rights reserved 1350-9047/00 $15.00 www.nature.com/cdd Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells ,1 1 1 2 MJ Clemens* , M Bushell , IW Jeffrey , VM Pain and Introduction SJ Morley2 Apoptosis is now recognized to be an important physiological 1 Department of Biochemistry and Immunology, Cellular and Molecular process by which cell and tissue growth, differentiation and Sciences Group, St George's Hospital Medical School, Cranmer Terrace, programmes of development are regulated. The molecular London SW17 ORE, UK mechanisms of apoptosis have been the subject of intense 2 Biochemistry Group, School of Biological Sciences, University of Sussex, research in recent years (for reviews see1±5). Cell death is Brighton BN1 9QG, UK induced following the stimulation of specific cell surface * Corresponding author: MJ Clemens, Department of Biochemistry and Immunology, Cellular and Molecular Sciences Group, St George's Hospital receptors such as the CD95 (Apo-1/Fas) antigen or the 6 Medical School, Cranmer Terrace, London SW17 ORE, UK. Tel: +44 20 8725 tumour necrosis factor-a (TNFa) receptor-1 (TNFR-1). It can 5770; Fax: +44 20 8725 2992; E-mail: [email protected] also result from intracellular events such as DNA damage or from a lack of specific growth factors. The relative importance Received 6.12.99; revised 25.1.00; accepted 20.3.00 of these different influences varies between cell types. The Edited by M Piacentini apoptotic process can be divided into a commitment phase and an execution phase.
    [Show full text]
  • Single-Molecule Analysis of Ribosome and Initiation Factor Dynamics During the Late Stages of Translation Initiation
    Single-Molecule Analysis of Ribosome and Initiation Factor Dynamics during the Late Stages of Translation Initiation Daniel David MacDougall Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2012 ©2012 Daniel David MacDougall All Rights Reserved Abstract Single-Molecule Analysis of Ribosome and Initiation Factor Dynamics during the Late Stages of Translation Initiation Daniel David MacDougall Protein synthesis in all organisms is catalyzed by a highly-conserved ribonucleoprotein macromolecular machine known as the ribosome. Prior to each round of protein synthesis in the cell, a functional ribosomal complex is assembled from its component parts at the start site of a messenger RNA (mRNA) template during the process of translation initiation. In bacteria, rapid and high-fidelity translation initiation is promoted by three canonical initiation factors: IF1, IF2, and IF3. In this thesis, I report the use of single-molecule fluorescence methods to study the role of the initiation factors and ribosome-factor interactions in regulating molecular events that occur during late stages of the translation initiation pathway. In Chapter 1, I provide a structural and biochemical framework for understanding one of the key events of the initiation pathway: docking of the large (50S) ribosomal subunit with the small subunit 30S initiation complex (30S IC). The 50S subunit joining reaction is catalyzed by GTP-bound IF2 and results in formation of a 70S initiation complex (70S IC) that contains an initiator transfer RNA (tRNA) and is primed for formation of the first peptide bond. During 50S subunit joining, IF2-GTP establishes interactions with RNA and protein components of the 50S subunit’s GTPase-associated center (GAC), which play an important role in subunit recruitment as well as the subsequent activation of GTP hydrolysis by IF2.
    [Show full text]
  • EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis Through ATF4 and C-MYC
    Published OnlineFirst October 10, 2018; DOI: 10.1158/2159-8290.CD-18-0606 RESEARCH ARTICLE EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC Gnana P. Krishnamoorthy 1 , Natalie R. Davidson 2 , Steven D. Leach 1 , Zhen Zhao 3 , Scott W. Lowe 3 , Gina Lee 4 , Iňigo Landa 1 , James Nagarajah 1 , Mahesh Saqcena 1 , Kamini Singh 3 , Hans-Guido Wendel3 , Snjezana Dogan 5 , Prasanna P. Tamarapu 1 , John Blenis 4 , Ronald A. Ghossein 5 , Jeffrey A. Knauf 1 , 6 , Gunnar Rätsch 2 , and James A. Fagin 1 , 6 ABSTRACT Translation initiation is orchestrated by the cap binding and 43S preinitiation com- plexes (PIC). Eukaryotic initiation factor 1A (EIF1A) is essential for recruitment of the ternary complex and for assembling the 43S PIC. Recurrent EIF1AX mutations in papillary thyroid cancers are mutually exclusive with other drivers, including RAS . EIF1AX mutations are enriched in advanced thyroid cancers, where they display a striking co-occurrence with RAS , which cooperates to induce tumorigenesis in mice and isogenic cell lines. The C-terminal EIF1AX-A113splice mutation is the most prevalent in advanced thyroid cancer. EIF1AX-A113splice variants stabilize the PIC and induce ATF4, a sensor of cellular stress, which is co-opted to suppress EIF2α phosphorylation, enabling a gen- eral increase in protein synthesis. RAS stabilizes c-MYC, an effect augmented by EIF1AX-A113splice. ATF4 and c-MYC induce expression of amino acid transporters and enhance sensitivity of mTOR to amino acid supply. These mutually reinforcing events generate therapeutic vulnerabilities to MEK, BRD4, and mTOR kinase inhibitors. SIGNIFICANCE: Mutations of EIF1AX, a component of the translation PIC, co-occur with RAS in advanced thyroid cancers and promote tumorigenesis.
    [Show full text]
  • Relevance of Translation Initiation in Diffuse Glioma Biology and Its
    cells Review Relevance of Translation Initiation in Diffuse Glioma Biology and its Therapeutic Potential Digregorio Marina 1, Lombard Arnaud 1,2, Lumapat Paul Noel 1, Scholtes Felix 1,2, Rogister Bernard 1,3 and Coppieters Natacha 1,* 1 Laboratory of Nervous System Disorders and Therapy, GIGA-Neurosciences Research Centre, University of Liège, 4000 Liège, Belgium; [email protected] (D.M.); [email protected] (L.A.); [email protected] (L.P.N.); [email protected] (S.F.); [email protected] (R.B.) 2 Department of Neurosurgery, CHU of Liège, 4000 Liège, Belgium 3 Department of Neurology, CHU of Liège, 4000 Liège, Belgium * Correspondence: [email protected] Received: 18 October 2019; Accepted: 26 November 2019; Published: 29 November 2019 Abstract: Cancer cells are continually exposed to environmental stressors forcing them to adapt their protein production to survive. The translational machinery can be recruited by malignant cells to synthesize proteins required to promote their survival, even in times of high physiological and pathological stress. This phenomenon has been described in several cancers including in gliomas. Abnormal regulation of translation has encouraged the development of new therapeutics targeting the protein synthesis pathway. This approach could be meaningful for glioma given the fact that the median survival following diagnosis of the highest grade of glioma remains short despite current therapy. The identification of new targets for the development of novel therapeutics is therefore needed in order to improve this devastating overall survival rate. This review discusses current literature on translation in gliomas with a focus on the initiation step covering both the cap-dependent and cap-independent modes of initiation.
    [Show full text]
  • Dependent Phosphorylation of Eukaryotic Elongation Factor 2(Eef-2) in Chinese Hamster Ovary Cells
    EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 33, No. 4, 198-204, December 2001 Effect of serum and hydrogen peroxide on the Ca2+/calmodulin- dependent phosphorylation of eukaryotic elongation factor 2(eEF-2) in Chinese hamster ovary cells Kee Ryeon Kang1,2 and So-Young Lee1 Introduction 1 Department of Biochemistry and Gyeongsang Institute of Health The regulation of protein synthesis in eukaryotes is inte- Science, Gyeongsang National University College of Medicine, grated with the translation process and other metabolic Chinju 660-751, Korea pathways of the cell, i.e. altered translation rates occur 2 Corresponding author: Tel, +82-55-751-8730; during mitosis, upon nutrient starvation or oxidant stress, Fax, +82-55-759-8005; E-mail, [email protected] and following treatment with hormones or growth factors. The process of mRNA translation takes place by three Accepted 30 November 2001 distinct phases termed (peptide-chain) initiation, elonga- tion, and termination. The acute regulation of mRNA Abbreviations: eEF-2, eukaryotic elongation factor 2; CaM, calmod- translation depends on changes in the activity of initia- ulin; CHO, Chinese hamster ovary tion factors or elongation factors, which is also common- ly mediated by alteration in their states of phosphory- lation (Hershey et al., 1996). Elongation factor 2 (eEF- 2), one of two elongation factors involved in the elonga- Abstract tion phase of translation in higher eukaryotes, facilitates translocation of peptidyl-tRNA from the ribosomal A site Eukaryotic elongation factor eEF-2 mediates regula- to the P site. Phosphorylation of eEF-2 reduces the tory steps important for the overall regulation of affinity of the factor for the ribosome, thereby decreasing mRNA translation in mammalian cells and is acti- the rate of protein synthesis (Nilsson and Nygard, 1991).
    [Show full text]
  • Initiation Factor IF-3-Dependent Binding of Escherichia Coli
    Proc. Nat. Acad. Sci. USA Vol. 69, No. 7, pp. 1843-1847, July 1972 7 Initiation Factor IF-3-Dependent Binding of Escherichia coli Ribosomes and N-Formylmethionine Transfer-RNA to Rabbit Globin Messenger (puromycin/AUG codon/valyl-tRNA binding/protein synthesis/hemoglobin) MARKUS NOLL*, HANS NOLL*, AND JERRY B. LINGRELt * Department of Biological Sciences, Northwestern University, Evanston, Illinois 60201; and t Department of Biological Chemistry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45219 Communicated by V. L. Telegdi, April 17, 1972 ABSTRACT An initiation complex has been formed in Ribosomes were prepared from S-30 extracts (15) by sedi- high yields from E. coli ribosomes, 9S messenger RNA for mentation through a sucrose gradient in a B-29 zonal rotor. rabbit hemoglobin, and N-formylmethionine-tRNA. In- itiation factor IF-3 is required for the binding and puro- "Native" 30S subunits were isolated by adjusting the Mg++ mycin is required for the release of fMet. Valyl-tRNA fails concentration in the gradient to 6 mM and pooling the frac- to bind to the second codon, whereas a mixture of 15 tions corresponding to the 30S peak. The particles were then aminoacyl-tRNAs promotes incorporation. Together with centrifuged to form a pellet in an angle-head rotor, dissolved quantitative data, the findings suggest that IF-3 directs in buffer A (60 mM NH4Cl-10 mM MgAc2-20 mM Tris * HCl the ribosomes to an AUG codon on one of the two globin messengers, at a site that is different from the normal pH 7.5-10 mM 2-mercaptoethanol) and stored at -65°.
    [Show full text]
  • Ribosomal Protein SI and Polypeptide Chain Initiation in Bacteria (30S Subunit Subspecies/Gel Electrophoresis/Initiation Complex Formation) WLODZIMIERZ SZER*, JOSE M
    Proc. Nat. Acad. Sci. USA Vol. 72, No. 6, pp. 2325-2329, June 1975 Ribosomal Protein SI and Polypeptide Chain Initiation in Bacteria (30S subunit subspecies/gel electrophoresis/initiation complex formation) WLODZIMIERZ SZER*, JOSE M. HERMOSOt, AND STEVEN LEFFLER*$ * Department of Biochemistry, New York University School of Medicine, New York, N.Y. 10016; and t Roche Institute of Molecular Biology, Nutley, New Jersey 07110 Communicated by Severo Ochoa, March 3, 1975 ABSTRACT Among several subspecies of 30S subunits figures and tables. Before use, the subunits were activated by of Escheriehia coli observed by polyacrylamide-agarose warming for 5 min at 370 (13). gel electrophoresis, only the slow-moving, protein Si- containing subspecies participates in the formation of the Purification of E. coli protein S1 from the ribosomal wash 30S initiation complex with coliphage MS2 RNA as mRNA; was recently described (10). Nearly homogeneous S1 was also the other subspecies retain activity with AUG as mRNA; obtained from ribosomes by the procedure of Tal et al. (14), they are also active in the poly(U)-directed binding of followed by chromatography on agarose. The two preparations Phe-tRNA. Protein SI from Caulobacter crescentus sub- stitutes for E. coli SI despite the fact that C. crescentus were indistinguishable by sodium dodecyl sulfate/poly- ribosomes do not bind MS2 RNA. Under appropriate con- acrylamide gel electrophoresis. C. crescentus S1 was isolated in ditions, the entire population of E. coli 30S subunits can the course of purification of C. crescentus 30S ribosomal be isolated as the SI-containing subspecies. Protein SI proteins in Dr.
    [Show full text]
  • Viewed in (104)]
    The Role in Translation of Editing and Multi-Synthetase Complex Formation by Aminoacyl-tRNA Synthetases Dissertation Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Medha Vijay Raina, M.Sc. Ohio State Biochemistry Graduate Program The Ohio State University 2014 Dissertation Committee: Dr. Michael Ibba, Advisor Dr. Juan Alfonzo Dr. Irina Artsimovitch Dr. Kurt Fredrick Dr. Karin Musier-Forsyth Copyright by Medha Vijay Raina 2014 ABSTRACT Aminoacyl-tRNA synthetases (aaRSs) catalyze the first step of translation, aminoacylation. These enzymes attach amino acids (aa) to their cognate tRNAs to form aminoacyl-tRNA (aa-tRNA), an important substrate in protein synthesis, which is delivered to the ribosome as a ternary complex with translation elongation factor 1A (EF1A) and GTP. All aaRSs have an aminoacylation domain, which is the active site that recognizes the specific amino acid, ATP, and the 3′ end of the bound tRNA to catalyze the aminoacylation reaction. Apart from the aminoacylation domain, some aaRSs have evolved additional domains that are involved in interacting with other proteins, recognizing and binding the tRNA anticodon, and editing misacylated tRNA thereby expanding their role in and beyond translation. One such function of the aaRS is to form a variety of complexes with each other and with other factors by interacting via additional N or C terminal extensions. For example, several archaeal and eukaryotic aaRSs are known to associate with EF1A or other aaRSs forming higher order complexes, although the role of these multi-synthetase complexes (MSC) in translation remains largely unknown.
    [Show full text]